In 2011, South Africa implemented a policy to decentralize treatment for rifampin-resistant tuberculosis (TB) to reduce durations of hospitalization and enable local treatment. We assessed policy implementation in Western Cape Province, where services expanded from 6 specialized TB hospitals to 406 facilities, by analyzing National Health Laboratory Service data on TB during 2012-2015. We calculated the percentage of patients who visited a TB hospital <1 year after rifampin-resistant TB diagnosis, the median duration of their hospitalizations, and the total distance between facilities visited. We assessed temporal changes with linear regression and stratified results by location. Of 2,878 patients, 65% were from Cape Town. In Cape Town, 29% visited a TB hospital; elsewhere, 68% visited a TB hospital. We found that hospitalizations and travel distances were shorter in Cape Town than in the surrounding areas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920662PMC
http://dx.doi.org/10.3201/eid2703.203204DOI Listing

Publication Analysis

Top Keywords

rifampin-resistant tuberculosis
8
western cape
8
south africa
8
decentralized care
4
care rifampin-resistant
4
tuberculosis western
4
cape south
4
africa 2011
4
2011 south
4
africa implemented
4

Similar Publications

Article Synopsis
  • * First-line treatments are being challenged by resistance, leading to the need for more toxic second-line drugs, but new agents and treatment regimens, like the BPaLM protocol, show promise for better efficacy and shorter treatment times.
  • * Emerging strategies, including immunotherapy and cell therapies, aim to boost the immune response against TB, but significant obstacles remain in reaching the WHO's goal to end TB, especially due to resource diversion from the COVID-
View Article and Find Full Text PDF

Differential Host Gene Expression in Response to Infection by Different Strains-A Pilot Study.

Microorganisms

October 2024

Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, CA 95616, USA.

Tuberculosis (TB) represents a global public health threat and is a leading cause of morbidity and mortality worldwide. Effective control of TB is complicated with the emergence of multidrug resistance. Yet, there is a fundamental gap in understanding the complex and dynamic interactions between different strains and the host.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on type II toxin-antitoxin systems (mazEF3, vapBC3, and relJK) and their impact on antibiotic resistance in Mycobacterium tuberculosis, specifically looking at mutations in these genes among sensitive and resistant isolates.
  • - Researchers analyzed 153 M. tuberculosis samples, finding that lineage 2 had the highest rifampin resistance and that rpoB531 mutations were common in resistant strains.
  • - A significant mutation in the mazF3 gene was identified in all rifampin-resistant isolates, suggesting its role in the development of drug resistance, indicating the need for further research with a larger sample size.
View Article and Find Full Text PDF

Objective: Rifampin-resistant tuberculosis (RR-TB) remains a serious global public health concern. We assessed treatment outcomes and associated influencing factors among RR-TB patients in China.

Methods: This research enrolled 1339 patients who started RR-TB treatment between May 2018 and April 2020 in China retrospectively.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated death rates and predictors among patients with multidrug/rifampin-resistant tuberculosis (MDR/RR-TB) in South Korea from 2011 to 2017.
  • Among 7,226 cases, 699 (9.7%) died within an average of 167 days of starting treatment, with significant differences in timing between TB-related and non-TB-related deaths.
  • Key factors associated with higher mortality included older age, male sex, existing health conditions, low income, and specific TB characteristics, indicating high-risk groups that need targeted intervention to reduce mortality rates.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!